Xcout Intel
AMYRIS, INC.
Amyris, Inc. is a vertically integrated biomanufacturing company that converts plant sugars into hydrocarbon molecules, specialty ingredients, and consumer products using precision fermentation.
Subscribe to see AMYRIS, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
AMYRIS, INC. at a glance
AMYRIS, INC. is a biotechnology company headquartered in United States. It has raised at least $923.2M across the 15 funding rounds on record. Its most recent funding round raised $8M in September 2022. Xcout tracks 12 named people at AMYRIS, INC., including Kathy L. Fortmann (Chief Executive Officer). Xcout recorded 1 job posting from AMYRIS, INC. in the last 90 days.
AMYRIS, INC. leadership
- Kathy L. FortmannChief Executive Officer
- Sunil ChandranChief Technology Officer
- Adam BlaziakChief Operations Officer
- Lisa RoesslerChief Commercial Officer
- Doris ChoiGeneral Counsel & Secretary
- Annie TsongSenior Vice President, Corporate & Scientific Affairs
6 more named people on record for AMYRIS, INC., with roles, board committees and tenure — see the full roster →
AMYRIS, INC. funding rounds
At least $923.2M raised across the 15 rounds on record. The 6 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $8M | — | |
| SEC Form D filing | $200M | — | |
| SEC Form D filing | $93.7M | — | |
| SEC Form D filing | $19M | — | |
| SEC Form D filing | $74.7M | — | |
| SEC Form D filing | $60M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at AMYRIS, INC.
Xcout recorded 1 job posting from AMYRIS, INC. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see AMYRIS, INC.'s hiring signals →
AMYRIS, INC. competitors
A few of AMYRIS, INC.'s closest competitors — see the full list of competitors and alternatives →
Alvotech specializes in the development and manufacturing of biosimilars to expand access to affordable biologic medicines for patients worldwide. The company utilizes a vertically integrated approach spanning from cell line development to fill and finish manufacturing.
CarboCode is a biotechnology research company headquartered in Cantanhede, Portugal, focused on scalable production of human-identical sphingolipids for skincare and health applications.
AGC Biologics is a global contract development and manufacturing organization (CDMO) that provides services for protein-based biologics and advanced therapies, including mammalian and microbial production, viral vectors, cell therapy, plasmid DNA, and mRNA. The company supports biopharmaceutical developers by offering process development, analytical formulation, cGMP manufacturing, and fill-finish services to help bring life-changing treatments to market.
Bloom Labs Bio Inc. specializes in the development and manufacturing of biologics, biosimilars, recombinant proteins, monoclonal antibodies, prebiotics, and probiotics. Utilizing modern biotechnology platforms and advanced infrastructure, the company serves the pharmaceutical and life sciences sectors with therapeutic and health and wellness solutions.
BioHarvest Sciences Inc. functions as a biotechnology firm with operations segmented into Nutraceuticals and Pharmaceuticals. A key innovation is its proprietary botanical synthesis platform technology, which allows for the cultivation of active ingredients found within plant enzymes or cells. The company harnesses this advanced technology to craft evidence-based and clinically validated therapeutic products for both its nutraceutical and pharmaceutical offerings. Beyond its own development, it also provides contract development and manufacturing services. Its product portfolio includes various wellness items, notably VINIA, a dietary supplement derived from red grape cells, which delivers the full spectrum of polyphenols naturally present in red grapes. The company conducts business in Israel and the United States, with its corporate base in Vancouver, Canada.
Arranta Bio is a biotechnology contract development and manufacturing organization (CDMO) focused on microbiome-based therapeutics, including live biotherapeutic products. It serves biopharmaceutical companies with process development, analytical, and manufacturing services for these products.
Get AMYRIS, INC.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on AMYRIS, INC. in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- 15 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access